Interestingly, the work showed that activation of this signaling axis led to CRELD2 enrichment in the secretome of breast cancer cells and CRELD2‐mediated education of cancer‐associated fibroblasts to a tumor‐promoting form. The gene discussed is CRELD2; the disease is cancer.